Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether co-administration of rifampin with neratinib
has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or
excretes) of neratinib.